Dr Colin Seale Smith, DO | |
1700 13th Street Everett, Wa 98201, Everett, WA 98201 | |
(425) 621-2000 | |
Not Available |
Full Name | Dr Colin Seale Smith |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 15 Years |
Location | 1700 13th Street Everett, Wa 98201, Everett, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134357361 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | OP60304409 (Washington) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Providence Regional Medical Center Everett | Everett, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Wa Anesthesia Services, Pc | 9335298884 | 90 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by BioSante.
The New York Times looks at the relationship between U.S. foreign aid's ability to shape aid recipients' attitudes toward the U.S. The article includes the perspectives of former USAID administrators J. Brian Atwood, who led the agency under President Bill Clinton, and Andrew Natsios, who was the director under President George W. Bush.
In a study published in the Proceedings of the National Academy of Sciences (PNAS) on Aug. 6, an international team led by Igor Roninson, of the University of South Carolina and the Medical University of South Carolina, reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.
Parents and caregivers have traditionally relied on cribs, playpens and bassinets to protect children while they sleep. The massive crib recalls followed by the announcement in December 2010 by the United States Consumer Product Safety Commission to ban drop-side cribs have caused many families to question the safety of these products.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
› Verified 5 days ago
Entity Name | Providence Wa Anesthesia Services, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669615894 PECOS PAC ID: 9335298884 Enrollment ID: O20090513000135 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by BioSante.
The New York Times looks at the relationship between U.S. foreign aid's ability to shape aid recipients' attitudes toward the U.S. The article includes the perspectives of former USAID administrators J. Brian Atwood, who led the agency under President Bill Clinton, and Andrew Natsios, who was the director under President George W. Bush.
In a study published in the Proceedings of the National Academy of Sciences (PNAS) on Aug. 6, an international team led by Igor Roninson, of the University of South Carolina and the Medical University of South Carolina, reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.
Parents and caregivers have traditionally relied on cribs, playpens and bassinets to protect children while they sleep. The massive crib recalls followed by the announcement in December 2010 by the United States Consumer Product Safety Commission to ban drop-side cribs have caused many families to question the safety of these products.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Colin Seale Smith, DO 5947 44th Ave Sw, Seattle, WA 98136-1416 Ph: (954) 681-5650 | Dr Colin Seale Smith, DO 1700 13th Street Everett, Wa 98201, Everett, WA 98201 Ph: (425) 621-2000 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by BioSante.
The New York Times looks at the relationship between U.S. foreign aid's ability to shape aid recipients' attitudes toward the U.S. The article includes the perspectives of former USAID administrators J. Brian Atwood, who led the agency under President Bill Clinton, and Andrew Natsios, who was the director under President George W. Bush.
In a study published in the Proceedings of the National Academy of Sciences (PNAS) on Aug. 6, an international team led by Igor Roninson, of the University of South Carolina and the Medical University of South Carolina, reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.
Parents and caregivers have traditionally relied on cribs, playpens and bassinets to protect children while they sleep. The massive crib recalls followed by the announcement in December 2010 by the United States Consumer Product Safety Commission to ban drop-side cribs have caused many families to question the safety of these products.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
› Verified 5 days ago
James Raymond Larson, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1321 Colby Ave, Everett, WA 98201 Phone: 425-258-3678 Fax: 425-258-3048 | |
Robert E Vanvalkenburgh, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1321 Colby Ave, Everett, WA 98201 Phone: 425-258-3678 Fax: 425-258-3048 | |
Robert Kurt Bechtel, Anesthesiology Medicare: Medicare Enrolled Practice Location: 1321 Colby Ave, Everett, WA 98201 Phone: 425-258-3678 Fax: 425-258-3048 | |
Dr. Daniel N. Schneeweiss, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1321 Colby Ave, Everett, WA 98201 Phone: 425-261-2000 Fax: 425-261-4462 | |
Dr. Roxanne E Hertzog, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1100 Pacific Ave, Suite 100, Everett, WA 98201 Phone: 206-244-1212 Fax: 206-244-1223 | |
Dr. Eric Breeden, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1321 Colby Ave, Providence Washington Anesthesia Services, Everett, WA 98201 Phone: 425-404-5352 Fax: 425-404-5357 |